Renal ultrasound to detect hydronephrosis: a need for routine imaging after radical hysterectomy?


BACKGROUND:Hydronephrosis can be a side effect of radical hysterectomy for cervical cancer. The incidence of clinically relevant hydronephrosis has not been studied in a large sample and the benefit of early detection of hydronephrosis is not clear. OBJECTIVE:To assess the incidence of hydronephrosis, following radical hysterectomy and evaluate the usefulness of routine renal ultrasound (RH). METHODS:Retrospective study, January 1998 and December 2008. Cervical cancer patients (FIGO stage IBI-IIA), treated with radical hysterectomy and pelvic lymph node dissection with or without adjuvant radiotherapy, without surgical lesion of the ureter, followed-up 6 months in the Academic Medical Center Amsterdam. Routine renal ultrasound was performed four weeks after RH, and in some on indication before or after the routine ultrasound. We documented which interventions for hydronephrosis were performed and evaluated the profile of patients at risk for hydronephrosis. RESULTS:281 patients were included: 252 (90%) underwent routine renal ultrasound and 29 (10%) underwent imaging on indication before routine ultrasound. The overall incidence of hydronephrosis was 12%. In symptomatic patients, the incidence was 21% and 9% in asymptomatic women undergoing routine ultrasound. Four patients were invasively treated for hydronephrosis (1% of the total group) after imaging for clinical suspicion of hydronephrosis. Patients with hydronephrosis were significantly more often treated with radiotherapy than patients without (43% versus 25% (p=0.03). CONCLUSION:There is no place for routine renal ultrasound following radical hysterectomy. Patients should be instructed about the symptoms that may be related to hydronephrosis, to allow for renal ultrasound on indication.


Gynecol Oncol


Gynecologic oncology


Hazewinkel MH,Gietelink L,van der Velden J,Burger MP,Stoker J,Roovers JP




Has Abstract


2012-01-01 00:00:00














  • Class III NSRH: oncological outcome in 170 cervical cancer patients.

    abstract:OBJECTIVE:To analyze local recurrence rate (LRR), morbidities and oncologic outcome of class III nerve-sparing radical hysterectomy. PATIENTS AND METHODS:170 consecutive class III NSRH cases were performed. Nineteen patients were addressed directly to surgery whilst neoadjuvant chemotherapy was administered in 151 pat...

    journal_title:Gynecologic oncology

    pub_type: 杂志文章


    authors: Ditto A,Martinelli F,Hanozet F,Reato C,Solima E,Zanaboni F,Grijuela B,Carcangiu M,Haeusler E,Raspagliesi F

    更新日期:2010-11-01 00:00:00

  • Comparing mutation frequencies for homologous recombination genes in uterine serous and high-grade serous ovarian carcinomas: A case for homologous recombination deficiency testing in uterine serous carcinoma.

    abstract:OBJECTIVE:To compare the frequencies of somatic homologous recombination (HR) gene mutations identified in next-generation sequencing (NGS) genomic profiling of uterine serous carcinomas (USCs) and high-grade serous ovarian carcinomas (HGSOCs). METHODS:Data for this analysis was obtained from AACR Project GENIE, a mul...

    journal_title:Gynecologic oncology

    pub_type: 杂志文章


    authors: Wallbillich JJ,Morris RT,Ali-Fehmi R

    更新日期:2020-11-01 00:00:00

  • Neoadjuvant chemotherapy and chemotherapy cycle number: A national multicentre study.

    abstract:OBJECTIVES:Six cycles of consolidation chemotherapy have become the standard for ovarian cancer treatment regimen following primary cytoreduction, yet with neoadjuvant chemotherapy (NAC), only 3 consolidation cycles are used. This study examines the effects of number of chemotherapy cycles in women with ovarian cancer ...

    journal_title:Gynecologic oncology

    pub_type: 杂志文章,多中心研究


    authors: Altman AD,McGee J,May T,Lane K,Lu L,Xu W,Ghatage P,Rosen B

    更新日期:2017-11-01 00:00:00

  • Uptake of a cholesterol-rich emulsion by breast cancer.

    abstract:OBJECTIVE:Overexpression of low-density lipoprotein (LDL) receptors occurs in several cancer cell lines and offers a unique strategy for drug targeting by using LDL as vehicle. However, the native lipoprotein is difficult to obtain and handle. Previously, we showed that a lipidic emulsion (LDE) similar to the lipid str...

    journal_title:Gynecologic oncology

    pub_type: 杂志文章


    authors: Graziani SR,Igreja FA,Hegg R,Meneghetti C,Brandizzi LI,Barboza R,Amâncio RF,Pinotti JA,Maranhão RC

    更新日期:2002-06-01 00:00:00

  • The malignant potential of small cystic ovarian tumors in women over 50 years of age.

    abstract:OBJECTIVE:The aim of this study was to determine the risk of malignancy in cystic ovarian tumors < 10 cm in diameter in asymptomatic postmenopausal women or women >or =50 years of age. METHODS:All cystic ovarian tumors detected by transvaginal sonography screening in asymptomatic postmenopausal women or women > or =50...

    journal_title:Gynecologic oncology

    pub_type: 杂志文章


    authors: Bailey CL,Ueland FR,Land GL,DePriest PD,Gallion HH,Kryscio RJ,van Nagell JR Jr

    更新日期:1998-04-01 00:00:00

  • A phase II trial of bisantrene (CL216,942) in refractory epithelial ovarian cancer.

    abstract::Twenty-three evaluable patients with refractory epithelial ovarian cancer were treated with bisantrene (CL216,942). The drug was given as a single-dose injection every 3 weeks. One patient (4%) showed a partial response. The compound thus has limited activity against this malignancy. ...

    journal_title:Gynecologic oncology

    pub_type: 杂志文章


    authors: Kavanagh JJ,Gershenson DM,Saul PB,Copeland LJ

    更新日期:1986-01-01 00:00:00

  • Opportunities and challenges in ovarian cancer research, a perspective from the 11th Ovarian cancer action/HHMT Forum, Lake Como, March 2007.

    abstract::Advances in surgery and chemotherapy have improved the 5-year survival for patients with epithelial ovarian cancer, but have not impacted on the ultimate rate of cure in a disease that is diagnosed in late stage and that recurs in the majority of patients. "Omic" technologies promise to define genetically driven aberr...

    journal_title:Gynecologic oncology

    pub_type: 共识发展会议,杂志文章


    authors: Ashworth A,Balkwill F,Bast RC,Berek JS,Kaye A,Boyd JA,Mills G,Weinstein JN,Woolley K,Workman P

    更新日期:2008-03-01 00:00:00

  • Psychological impact of prophylactic oophorectomy in women at increased risk of developing ovarian cancer: a prospective study.

    abstract:OBJECTIVES:The objectives of this study were twofold: to prospectively assess whether expressed intention to undergo prophylactic oophorectomy translated into uptake and to evaluate the psychological impact of the procedure in a sample of unaffected women with a strong family history of breast/ovarian cancer. METHODS:...

    journal_title:Gynecologic oncology

    pub_type: 杂志文章


    authors: Tiller K,Meiser B,Butow P,Clifton M,Thewes B,Friedlander M,Tucker K

    更新日期:2002-08-01 00:00:00

  • Metabolic monitoring of advanced uterine cervical cancer neoadjuvant chemotherapy by using [F-18]-Fluorodeoxyglucose positron emission tomography: preliminary results in three patients.

    abstract:OBJECTIVE:The aim of this report is to describe the potential clinical utility of tracer [F-18]-Fluorodeoxyglucose (FDG) uptake, quantitated as a standardized uptake value (SUV) by positron emission tomography (PET), to evaluate treatment response to neoadjuvant chemotherapy (NAC) in advanced uterine cervical cancer. ...

    journal_title:Gynecologic oncology

    pub_type: 杂志文章


    authors: Yoshida Y,Kurokawa T,Kawahara K,Yagihara A,Tsuchida T,Okazawa H,Fujibayashi Y,Yonekura Y,Kotsuji F

    更新日期:2004-12-01 00:00:00

  • Vulvovaginal melanoma: report of seven cases and literature review.

    abstract::Five cases of primary vaginal melanoma were treated at UCLA Medical Center between 1976 and 1986. Two additional cases of melanoma arising at the junction of the vulva and vagina are presented. One of seven (13%) patients is alive, with a median time to recurrence of 7 months, and median survival of 31 months. Four of...

    journal_title:Gynecologic oncology

    pub_type: 杂志文章,评审


    authors: Brand E,Fu YS,Lagasse LD,Berek JS

    更新日期:1989-04-01 00:00:00

  • Gynecologic oncology providers endorse practice-changing impact of communication skills training.

    abstract:OBJECTIVE:Effective communication improves patient outcomes and is crucial to good patient care. Communication skills training (CST) has been shown to improve communication skills in non-gynecologic oncology specialties. We sought to develop and test CST for gynecologic oncology (GO) providers. METHODS:We developed an...

    journal_title:Gynecologic oncology

    pub_type: 杂志文章


    authors: Lefkowits C,Bevis K,Carey EC,Sheeder J,Arnold RM,Podgurski L

    更新日期:2019-06-01 00:00:00

  • Endometrial response to endogenous hormones after pelvic irradiation for genital malignancies.

    abstract::Two cases are presented which demonstrate histologically an endometrial response to endogenous hormones after pelvic teletherapy and brachytherapy in patients who have undergone lateral ovarian transposition. Reasons for such a response are briefly discussed. ...

    journal_title:Gynecologic oncology

    pub_type: 杂志文章


    authors: Larson JE,Whitney CW,Zaino R,Kaminski P,Podczaski E,Mortel R

    更新日期:1990-01-01 00:00:00

  • Potential of RASSF1A promoter methylation as biomarker for endometrial cancer: A systematic review and meta-analysis.

    abstract:BACKGROUND:An epigenetic approach to explaining endometrial carcinogenesis necessitates good understanding of Ras association domain family 1 isoform A (RASSF1A) promoter methylation data from primary studies. AIMS:Differential magnitude of reported associations between RASSF1A promoter methylation and endometrial can...

    journal_title:Gynecologic oncology

    pub_type: 杂志文章,meta分析,评审


    authors: Pabalan N,Kunjantarachot A,Ruangpratheep C,Jarjanazi H,Christofolini DM,Barbosa CP,Bianco B

    更新日期:2017-09-01 00:00:00

  • Phenotypic and functional characteristics of mononuclear cells in ovarian carcinoma tumors.

    abstract::By using monoclonal antibodies and flow cytometry, the phenotype and activation state [based on presence of interleukin 2 (IL-2) receptors] were determined on the mononuclear cell (MNC) fraction of ovarian carcinoma tissue from 12 patients. Thymidine incorporation response to IL-2 and phytohemagglutinin stimulation wa...

    journal_title:Gynecologic oncology

    pub_type: 杂志文章


    authors: Lentz SS,McKean DJ,Kovach JS,Podratz KC

    更新日期:1989-08-01 00:00:00

  • Preoperative hysteroscopic assessment of cervical invasion by endometrial carcinoma: a retrospective study.

    abstract:OBJECTIVE:The aim of this study was to evaluate the efficacy of hysteroscopy, using normal saline (NS) or carbon dioxide (CO2) as the distention medium, in assessing tumor invasion of the uterine cervix by endometrial carcinoma. METHODS:A retrospective study was conducted in 200 consecutive patients with endometrial c...

    journal_title:Gynecologic oncology

    pub_type: 杂志文章


    authors: Lo KW,Cheung TH,Yim SF,Chung TK

    更新日期:2001-08-01 00:00:00

  • A pilot randomized control trial to evaluate pelvic floor muscle training for urinary incontinence among gynecologic cancer survivors.

    abstract:OBJECTIVES:We previously reported high rates of urinary incontinence among gynecologic cancer survivors and aimed to evaluate the effectiveness of a simple intervention for treatment of urinary incontinence in this population. METHODS:We recruited 40 gynecologic cancer survivors who reported urinary incontinence on a ...

    journal_title:Gynecologic oncology

    pub_type: 杂志文章,随机对照试验


    authors: Rutledge TL,Rogers R,Lee SJ,Muller CY

    更新日期:2014-01-01 00:00:00

  • Hypermethylated DAPK in serum DNA of women with uterine leiomyoma is a biomarker not restricted to cancer.

    abstract:OBJECTIVE:Ovarian cancer is most frequently diagnosed at a late stage with a poor prognosis. No markers for early diagnosis have been established. Aberrantly methylated DNA appears as a promising molecular cancer marker. The aim of this study was to analyze the methylation status of the proapoptotic cancer related gene...

    journal_title:Gynecologic oncology

    pub_type: 杂志文章


    authors: Häfner N,Diebolder H,Jansen L,Hoppe I,Dürst M,Runnebaum IB

    更新日期:2011-04-01 00:00:00

  • Small cell carcinoma of the gynecologic tract: a multifaceted spectrum of lesions.

    abstract:OBJECTIVE:Small cell carcinoma (SmCC) of the female genital tract constitutes a diagnostic and clinical challenge given its rarity and the lack of standardized therapeutic approaches. Here we review the morphological, clinical and molecular features of gynecologic SmCCs and discuss potential areas for future research. ...

    journal_title:Gynecologic oncology

    pub_type: 杂志文章,评审


    authors: Atienza-Amores M,Guerini-Rocco E,Soslow RA,Park KJ,Weigelt B

    更新日期:2014-08-01 00:00:00

  • Expression of tenascin in human cervical cancer--association of tenascin expression with clinicopathological parameters.

    abstract:OBJECTIVE:Tenascin is an extracellular matrix glycoprotein, relevant for embryonal and fetal development, which is reexpressed in the stroma of benign and malignant tumors. Little is known about the molecular interaction of tenascin during neoplastic transformation and tumor progression in cervical cancer. METHOD:We s...

    journal_title:Gynecologic oncology

    pub_type: 杂志文章


    authors: Pilch H,Schäffer U,Schlenger K,Lautz A,Tanner B,Höckel M,Knapstein PG

    更新日期:1999-06-01 00:00:00

  • A phase I, single-arm, open-label, dose escalation study of intraperitoneal cisplatin and doxorubicin in patients with recurrent ovarian cancer and peritoneal carcinomatosis.

    abstract:OBJECTIVE:We performed a phase I, single-arm, non-randomized, open-label, dose-escalation trial to determine the dose-limiting toxicity of intraperitoneal cisplatin and doxorubicin applied as pressurized intraperitoneal aerosol chemotherapy (PIPAC) in women with recurrent ovarian cancer. METHODS:We used a standard 3 +...

    journal_title:Gynecologic oncology

    pub_type: 杂志文章


    authors: Tempfer CB,Giger-Pabst U,Seebacher V,Petersen M,Dogan A,Rezniczek GA

    更新日期:2018-07-01 00:00:00

  • Anticancer effects of (-)-epigallocatechin-3-gallate on ovarian carcinoma cell lines.

    abstract:PURPOSE:A constituent of green tea, (-)-epigallocatechin-3-gallate (EGCG), has been known to possess anti-cancer properties. In this study, we investigated the time-course anticancer effects of EGCG on human ovarian cancer cells to provide insights into the molecular-level understanding of growth suppression mechanism ...

    journal_title:Gynecologic oncology

    pub_type: 杂志文章


    authors: Huh SW,Bae SM,Kim YW,Lee JM,Namkoong SE,Lee IP,Kim SH,Kim CK,Ahn WS

    更新日期:2004-09-01 00:00:00

  • Predictive factors for long-term survival in patients with advanced ovarian cancer.

    abstract::A total of 107 patients with carcinoma of the ovary were entered in a study combining extensive primary surgery and intensive chemotherapy. Because of evidence supporting the effectiveness of both single agent platinum (P) and the combination of cyclophosphamide and doxorubicin (CA), patients were treated with alterna...

    journal_title:Gynecologic oncology

    pub_type: 杂志文章


    authors: Krag KJ,Canellos GP,Griffiths CT,Knapp RC,Parker LM,Welch WR,Klatt M,Andersen J

    更新日期:1989-07-01 00:00:00

  • Chylous ascites following para-aortic lymphadenectomy: a case report.

    abstract:BACKGROUND:Chylous ascites is an uncommon complication following para-aortic lymph node dissection in the management of gynecologic malignancies. Treatment options are serial paracentesis, medium-chain triglyceride diet, total parenteral nutrition and somatostatin as conservative management and peritoneovenous shunting...

    journal_title:Gynecologic oncology

    pub_type: 杂志文章


    authors: Boran N,Cil AP,Tulunay G,Ozgul N,Kose MF

    更新日期:2004-06-01 00:00:00

  • The benefits of low anterior en bloc resection as part of cytoreductive surgery for advanced primary and recurrent epithelial ovarian cancer patients outweigh morbidity concerns.

    abstract:OBJECTIVES:The aim of this study was to assess the safety, efficacy and impact on survival of low anterior resection and primary anastomosis at the time of en bloc resection for primary and recurrent epithelial ovarian carcinoma. METHODS:We performed a retrospective review of 46 primary and 14 recurrent epithelial ova...

    journal_title:Gynecologic oncology

    pub_type: 杂志文章


    authors: Park JY,Seo SS,Kang S,Lee KB,Lim SY,Choi HS,Park SY

    更新日期:2006-12-01 00:00:00

  • Characteristics relating to ovarian cancer risk: implications for prevention and detection.

    abstract::Approximately 20,000 women are diagnosed with ovarian cancer in the United States each year, and some 12,000 women die because of it. Epithelial ovarian cancer, the most common histopathologic type, is uncommon before age 40 years, after which incidence rates increase steeply until age 70-79 years and then decrease so...

    journal_title:Gynecologic oncology

    pub_type: 杂志文章,评审


    authors: Whittemore AS

    更新日期:1994-12-01 00:00:00

  • Endometrial carcinoma: steroid receptors and response to medroxyprogesterone acetate.

    abstract::The steroid receptor content of the primary endometrial cancer of 22 patients who were treated for recurrent or advanced disease has been measured and correlated with response to medroxyprogesterone acetate. No patient with a progesterone receptor (PR)-negative tumor responded and only 2 patients with PR-positive tumo...

    journal_title:Gynecologic oncology

    pub_type: 杂志文章


    authors: Quinn MA,Cauchi M,Fortune D

    更新日期:1985-07-01 00:00:00

  • Bilateral ultrastaging of sentinel lymph node in cervical cancer: Lowering the false-negative rate and improving the detection of micrometastasis.

    abstract:OBJECTIVE:To evaluate the sensitivity of sentinel node (SN) ultrastaging and to define parameters that may reduce the overall false-negative rate in women with early-stage cervical cancer. METHODS:We analyzed data from a large retrospective multicenter cohort group with FIGO stages IA-IIB cervical cancer in whom at le...

    journal_title:Gynecologic oncology

    pub_type: 杂志文章,多中心研究


    authors: Cibula D,Abu-Rustum NR,Dusek L,Slama J,Zikán M,Zaal A,Sevcik L,Kenter G,Querleu D,Jach R,Bats AS,Dyduch G,Graf P,Klat J,Meijer CJ,Mery E,Verheijen R,Zweemer RP

    更新日期:2012-12-01 00:00:00

  • Detection of human papillomavirus genome and analysis of expression of c-myc and Ha-ras oncogenes in invasive cervical carcinomas.

    abstract::Invasive carcinomas of the uterine cervix of 38 patients were examined for the presence of human papillomavirus (HPV) genomes and for the state of the c-myc and Ha-ras oncogenes. A combination of Southern blot hybridization and polymerase chain reaction revealed the presence of the genome of HPV type 16 in 17 tumors (...

    journal_title:Gynecologic oncology

    pub_type: 杂志文章


    authors: Iwasaka T,Yokoyama M,Oh-uchida M,Matsuo N,Hara K,Fukuyama K,Hachisuga T,Fukuda K,Sugimori H

    更新日期:1992-09-01 00:00:00

  • Fallopian tube abnormalities in uterine serous carcinoma.

    abstract:OBJECTIVE:Uterine serous carcinoma (USC) is presumed to arise from endometrial intra-epithelial carcinoma (EIC), whereas tubo-ovarian high-grade serous carcinomas have similar precursor lesions in the Fallopian tube, i.e. serous tubal intra-epithelial carcinoma (STIC). The presence of Fallopian tube abnormalities and t...

    journal_title:Gynecologic oncology

    pub_type: 杂志文章


    authors: Steenbeek MP,Bulten J,Snijders MPLM,Lombaers M,Hendriks J,van den Brand M,Kraayenbrink AA,Massuger LFAG,Sweegers S,de Hullu JA,Pijnenborg JMA,Küsters-Vandevelde HVN,Reijnen C

    更新日期:2020-08-01 00:00:00

  • Risk assessment model for overall survival in patients with locally advanced cervical cancer treated with definitive concurrent chemoradiotherapy.

    abstract:OBJECTIVE:To develop a nomogram for predicting the probability of 5year survival after definitive concurrent chemoradiotherapy (CCRT) in locally advanced cervical cancer (LACC). METHODS:Between 1998 and 2008, 209 patients with LACC were treated with definitive CCRT. Multivariate analysis using Cox proportional hazards...

    journal_title:Gynecologic oncology

    pub_type: 杂志文章


    authors: Shim SH,Lee SW,Park JY,Kim YS,Kim DY,Kim JH,Kim YM,Kim YT,Nam JH

    更新日期:2013-01-01 00:00:00